NattoPharma ASA has announced a key management position: Hogne Vik is the new CEO as selected by the Board of Directors of the company. Dr. Hogne Vik is a physician by education and has a long and successful track record in both the pharmaceutical and dietary supplement industries. As global VP in product development in Nycomed/Nycomed Amersham Dr. Vik was one of the main forces behind the development and market entrance of VisiPaque, a truly world-dominating X-ray contrast agent that remains a top-selling pharmaceutical compound in the US.

Following Nycomed, Vik was instrumental in bringing Tonalin (CLA) to the European and US market, as part of Natural ASA. Most recently, Dr. Vik has been the driving force behind the documentation program securing the current marketing position of Superba Krill Oil developed and manufactured by Aker BioMarine Antarctic.